Copyright
©The Author(s) 2019.
World J Transplant. Jun 28, 2019; 9(2): 35-47
Published online Jun 28, 2019. doi: 10.5500/wjt.v9.i2.35
Published online Jun 28, 2019. doi: 10.5500/wjt.v9.i2.35
Ref. | eGFR | Cr | ||||
PPI | No PPI | P | PPI | No PPI | P | |
Knorr et al[20] | 53.1 ± 20.21 | 55.1 ± 20.6 | 0.29 | NR | NR | - |
van Boekel et al[22] | 49.5 ± 12.3 | 50.7 ± 12.5 | NS | 1.5 ± 0.4 at 3 mo | 1.5 ± 0.4 | NS |
Patel et al[23] | 49.0 (39.4–63.2)2 | 49.9 (39.3–60.8) | 0.78 | NR | NR | - |
Uludag et al[37] | - | - | - | 1.49 ± 0.99 mg/dL | 1.24 ± 0.46 mg/dL | 0.017 |
Alhosaini et al[34] | 49.4 ± 14.9 | 52.8 ± 14.3 | 0.29 | - | - | - |
Kipp et al[39] | NR | NR | - | 1.896 ± 1.53 | 1.812 ± 1.25 | P = 0.4098 |
- Citation: Boonpheng B, Thongprayoon C, Bathini T, Sharma K, Mao MA, Cheungpasitporn W. Proton pump inhibitors and adverse effects in kidney transplant recipients: A meta-analysis. World J Transplant 2019; 9(2): 35-47
- URL: https://www.wjgnet.com/2220-3230/full/v9/i2/35.htm
- DOI: https://dx.doi.org/10.5500/wjt.v9.i2.35